Skip to main content

The Cigna Group(CI-N)

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Express Scripts Adds Three Biosimilars to Largest Formulary to Promote Competition and Advance Affordability, Choices for Patients

PR Newswire - Mon Jul 10, 9:00AM CDT

ST. LOUIS, July 10, 2023 /PRNewswire/ -- Express Scripts, the pharmacy benefits management (PBM) business of The Cigna Group's (NYSE: CI) Evernorth, announced today that as part of its commitment to driving greater affordability for clients and people living with inflammatory conditions, it will add three additional biosimilars to its National Preferred Formulary (NPF). The addition of these products that offer competitive net costs to HUMIRA, the top selling pharmaceutical drug in the world, will also support greater patient access and choice.


Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.